Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EQIX | IBKR |
|---|---|---|
| Price | $1,043.74 | $90.00 |
| Change today | ▲ 0.59% | ▼ 1.70% |
| Market cap | $102.39B | $40.78B |
| Return, 3 months | -4.2% | -2.9% |
| Return, year to date | +38.3% | +40.4% |
| Return, 1 year | +35.0% | +40.2% |
| P/E (TTM) | – | 35.7 |
| P/B | – | 6.9 |
| P/E percentile vs own 5y | 1st | 91st |
| Dividend yield | – | 0.36% |
| Revenue growth (YoY, latest qtr) | +16.4% | +21.3% |
| Net profit growth (YoY) | +30.0% | +33.0% |
| Gross margin | 51.5% | 90.2% |
| Operating margin | 23.0% | 86.5% |
| Net margin | 15.6% | 10.2% |
| Return on equity | 10.8% | 21.0% |
| Analyst target vs. price | +19.7% | +21.5% |
| Analyst buy share | 87% | 67% |
| RSI (14) | 53 | 53 |
| 30-day volatility | 26.6% | 41.1% |
| Max drawdown, 1 year | -13.7% | -18.7% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.